ZYTO Corp Obtains Blue Sky in up to 38 States with Approval of Standard & Poor’s (S&P) Corporate Listing Program

OREM, Utah--(BUSINESS WIRE)--ZYTO Corp (Pink Sheets: ZYTC) (www.ZYTO.com) announced today that the Editorial Board of Standard and Poor’s (“S&P”) has approved ZYTO for their Corporation Records Listing Program. Standard & Poor’s Corporation Records is considered the premier source for information on U.S. and international public companies by investors and compliance professionals. As part of the approval, a full description of ZYTO will be published in the Daily News Section of Standard Corporation Records early next week, a recognized securities manual for secondary trading in up to 38 states under the Blue Sky Laws. In addition, ZYTO’s company information will be published in the December volume of Standard and Poor’s Corporation Records Manual, which will be available by early February 2010.

“Through this program, ZYTO’s company information will be made available including an in-depth description of ZYTO’s business operations, share price, dividend history, shares outstanding, financial position, and earnings.”

Standard Corporation Records are available in print, CD-ROM, and via the Web at www.netadvantage.standardandpoors.com as well as through numerous electronic vendors.

According to Kami Howard, CFO of ZYTO, “Through this program, ZYTO’s company information will be made available including an in-depth description of ZYTO’s business operations, share price, dividend history, shares outstanding, financial position, and earnings.”

About ZYTO Corp

ZYTO Corp was founded by its CEO Dr. Vaughn R Cook, OMD. The company designs and builds computer technology to facilitate decision making about healthcare and wellness options. ZYTO’s product mix includes the Pro, Balance and EVOX, sold exclusively by healthcare professionals, and the Compass System built for distributors involved with specific direct sales or network marketing companies.

These products are not medical devices and do not diagnose or treat any illness; they are used to gather health specific information using a proprietary process called a biosurvey. Biosurveys provide information that facilitates better decisions.

For more information about ZYTO, visit www.ZYTO.com or contact their Headquarters at 801-224-7199.

Forward-looking statements in this release are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties, including, without limitation, continued acceptance of the Company's products, increased levels of competition, new products and technological changes, dependence upon third-party suppliers, intellectual property rights, and other risks detailed from time to time in the Company's periodic reports.